Donald School Journal of Ultrasound in Obstetrics and Gynecology

Register      Login

VOLUME 8 , ISSUE 1 ( January-March, 2014 ) > List of Articles


Psychotropic Medication Use during Pregnancy and Lactation: Role of Ultrasound Assessment

Ritsuko Pooh, Andrew Matthys, Maria Teresa Ambat

Keywords : Psychotropic medication,Pregnancy,Birth defects,Teratogens,Ebstein's anomaly,Withdrawal,SSRIs,TCAs,Anticonvulsants,Valproate,Valproic acid,Carbamazepine,Lamotrigine,Antipsychotics,Haloperidol,Olanzapine,Benadryl,Lithium

Citation Information : Pooh R, Matthys A, Ambat MT. Psychotropic Medication Use during Pregnancy and Lactation: Role of Ultrasound Assessment. Donald School J Ultrasound Obstet Gynecol 2014; 8 (1):109-121.

DOI: 10.5005/jp-journals-10009-1345

License: CC BY-NC 4.0

Published Online: 01-12-2014

Copyright Statement:  Copyright © 2014; The Author(s).


How to cite this article

Matthys A, Ambat MT, Pooh R, Kupesic Plavsic S. Psychotropic Medication Use during Pregnancy and Lactation: Role of Ultrasound Assessment. Donald School J Ultrasound Obstet Gynecol 2014;8(1):109-121.

PDF Share
  1. USCB. Available at: on August 24, 2012)‥
  2. September 1, 1992 through March 31, 2001. Available at: report.pdf (Accessed on October 18, 2013)‥
  3. Drug usage in pregnancy. In: Lewis P, editor. Clinical pharmacology in obstetrics. Boston, Wright-PSG, 1983;p. 22-35.
  4. Embryotoxic drugs. Bio Res Pregnancy Perinatol 1985; 6:1-4.
  5. Problems of Lithium maintenance treatment during pregnancy, delivery and lactation. Agressolgie 1980; 21:714-716.
  6. Drugs in pregnancy and lactation. 2nd ed. Baltimore: Williams & Wilkins, 1986;p. 321-329.
  7. The use of lithium during pregnancy and lactation. J Clin Psychiatry 1983;44:358-365.
  8. When a woman taking lithium wants to have a baby. Massachusetts General Hospital Newsletter. Biol Ther Psychiatry 1983;6:19-24.
  9. Lithium treatment of women during pregnancy and the post-delivery period. In Johnson FN, editor. Handbook of Lithium Therapy. Lancaster, England: MTP Press 1980;p. 421-429.
  10. Lithium-related congenital cardiac abnormalities: Prenatal screening. Massachusetts General Hospital Newsletter Biol Ther Psychiatry 1983;6:7-12.
  11. Letter: Prenatal echocardiographic screening for Ebstein's anomaly for mothers on lithium therapy. Lancet 1982;2:875-878.
  12. Outcome after rapid discontinuation of lithium treatment in bipolar mood disorders. Arch Gen Psychiatry 1993; 50:448-453.
  13. Prospective multicentre study of pregnancy outcome after lithium exposure during first trimester. Lancet 1992; 339:530-533.
  14. Letter: Lithium and placenta. Am J Obstet Gynecol 1975; 122:541-547.
  15. Nephrogenic diabetes insipidus in transplacental lithium intoxication. J Pediatr 1979; 94:493-502.
  16. Psychotropic medication in pregnancy. Advances in Psychiatric Treatment 2004;10:59-66.
  17. Pregnancy outcome following gestational exposure to venlaxafine: A multicenter prospective controlled study. Am J Psychiatry 2001;158:1728-1733.
  18. Association between cleft lip with or without cleft palate and prenatal exposure to diazepam. Lancet 1975;2:478-484.
  19. Lack of relation of oral clefts to diazepam use during pregnancy. N Engl J Med 1983; 309:1282-1285.
  20. Diazepam in labour: Its metabolism and effect on the clinical condition and thermogenesis of the newborn. BMJ 1973; 4:251-257.
  21. Withdrawal symptoms in the neonates from intrauterine exposure to diazepam. J Pediatr 1977; 90: 123-130.
  22. Side effects on fetus and infant of psychotropic drug use during pregnancy. Int Pharmacopsychiatry 1976; 11:246-252.
  23. Neonatal alprazolam withdrawalpossible effects of breast feeding. Drug Intell Clin Pharm 1989; 23:614-620.
  24. Letter: Abnormalities in children exposed to benzodiazepines in utero. Lancet 1987; 1:108-115.
  25. Maternal health and congenital defect. N Engl J Med 1958; 258:767-772.
  26. Pregnancy outcome following first trimester exposure to fluoxetine (Prozac). JAMA 1993; 269:2246-2252.
  27. Birth defects and drugs in pregnancy. Littleton, MA: PSG Publishing 1977;pp 345-347.
  28. Course of psychiatric disorders in pregnancy: dilemmas in pharmacological management. Neurol Clin 1994;12:6138.
  29. The fetal valproate syndrome. Am J Med Genet 1984 19:47380.
  30. Fetal valproate syndrome: Is there a recognizable phenotype? J Med Genet 1987;24:692-696.
  31. Fetal growth, major malformations and minor anomalies in infants born to women receiving valproic acid. J Pediatr 1986; 108:997-999.
  32. Prenatal exposure to valproic acid during pregnancy and limb deficiencies: a case control study. Am J Med Genet 2000;9:376-382.
  33. The outcome of pregnancy in 689 women exposed to therapeutic doses of antidepressants: a collaborative study of the European Network of Teratology Information Services (ENTIS). Reproductive Toxicology 1996; 10:285-290.
  34. Pharmacologic management of psychiatric illness during pregnancy: Dilemmas and guidelines. American Journal of Psychiatry 1996;153:592-606.
  35. Delivery outcome after the use of antidepressants in early pregnancy. European Journal of Clinical Pharmacology 1999; 55: 503-508.
  36. Management of major depression during pregnancy. American Journal of Psychiatry 2002;159: 1667-1673.
  37. Antidepressant use during lactation. Journal of Human Lactation 2001;17:256-261.
  38. Antidepressant treatment during breast-feeding. American Journal of Psychiatry 1996; 153:1132-1137.
  39. Benzodiazepine use in pregnancy and major malformations or oral cleft. Meta-analysis of cohort and casecontrolled studies. BMJ 1998;317:839-843.
  40. Intrauterine hemorrhage associated with prenatal valproate exposure. Am J Genet 1998;64(Suppl 4):A159.
  41. Effects of antimanic mood stabilizing drugs on fetuses, neonates and nursing infants. South Med J 2001;94:304-305.
  42. Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study. JAMA 1998; 279:609.
  43. Exposure to nonsteroidal antiinflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. BMJ 2003;327:368.
  44. Risk of adverse birth outcome and miscarriage in pregnant users of nonsteroidal anti-inflammatory drugs: population based observational study and case-control study. BMJ 2001; 322:266-269.
  45. Maternal serum-alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Report of UK collaborative study on alpha-fetoprotein in relation to neural-tube defects. Lancet 1977; 1:1323-1330.
  46. Ultrasound screening for spina bifida: cranial and cerebellar signs. Lancet 1986;2:724.
  47. Amniotic fluid acetylcholinesterase measurement in the prenatal diagnosis of open neural tube defects. Second report of the collaborative acetylcholinesterase Study. Prenat Diagn 1989; 9:813.
  48. Fetal MRI in the evaluation of fetuses referred for sonographically suspected neural tube defects (NTDs): impact on diagnosis and management decision. Neuroradiology 2009; 51:761.
  49. Efficacy of prenatal ultrasonography in confirmed club foot. J Bone Joint Surg Br 2002;84:1015.
  50. The risk for congenital heart defects in offspring of individuals with congenital heart defects. Clin Genet 2001; 59:325.
  51. Report of the New England Regional Infant Cardiac Program by Donald C. Fyler, MD, Pediatrics, 1980;65(suppl):375-461. Pediatrics 1998; 102:258.
  52. Cyanosis of the newborn infant. Recognition and clinical evaluation. J Pediatr 1970;77:484.
  53. Lamotrigine treatment as monotherapy during pregnancy. J Neurol 248(Suppl 2):146, 2001.
  54. Epilepsy and Pregnancy: A Prospective Register in the United Kingdom. Post presented at the XVII World Congress of Neurology London, GBR, June, 2001.
  55. Ebstein's malformation: a clinical and laboratory study. Medicine (Baltimore) 1956;35:161.
  56. Left heart lesions in patients with Ebstein anomaly. Mayo Clin Proc 2005; 80:361.
  57. Electrode catheters and the diagnosis of Ebstein's anomaly of the tricuspid valve. Br Heart J 1966; 28:161.
  58. Ebstein's anomaly associated with cardiomyopathy and pulmonary hypertension. Circulation 1964; 30:578.
  59. Two-dimensional echocardiographic spectrum of Ebstein's anomaly: detailed anatomic assessment. J Am Coll Cardiol 1984; 3:356.
  60. Neurological examination: Normal and abnormal features. In: Neurology of the Newborn, 4th ed, WB Saunders, Philadelphia 2001. p. 103.
  61. Clinical practice. Depression during pregnancy. N Engl J Med 2011; 365:1605.
  62. Available at: on December 15, 2011)‥
  63. Therapeutic drug monitoring in pregnant and postpartum women: recommendations for SSRIs, lamotrigine, and lithium. J Clin Psychiatry 2010;71:649.
  64. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2006;77:193.
  65. Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations. Arch Neurol 2011; 68:1275.
  66. Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy. Neurology 2008;70:2152.
  67. Use and safety of antipsychotic drugs during pregnancy. J Psychiatr Pract 2009;15:183.
  68. Management of bipolar disorder during pregnancy and the postpartum period. Am J Psychiatry 2004;161:608.
  69. Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines. Am J Psychiatry 1996;153:592.
  70. Antenatal exposure to meprobamate and chlordiazepoxide in relation to malformations, mental development, and childhood mortality. N Engl J Med 1975; 292:726-729.
  71. Pregnancy registries in epilepsy: a consensus statement on health outcomes. Neurology 2008; 71:1109-1113.
  72. Use of selective serotoninreuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med 2007;356:26848.
  73. First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N Engl J Med 2007;356:2675-2679.
  74. Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations. Birth Defects Res A Clin Mol Teratol 2007;79:301-306.
  75. Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study. BMJ 2010; 341:c6581.
  76. Teratogenicity of antiepileptic drug combinations with special emphasis on epoxidation (of carbamazepine). Epilepsia 1984; 25:7782.
  77. Benzodiazepine use in pregnancy and major malformations or oral cleft: metaanalysis of cohort and case-control studies. BMJ 1998; 317: 839-842.
  78. Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations. Pharmacoepidemiol Drug Saf 2007;16:1203-1205.
  79. Drugs in pregnancy. N Engl J Med 1998; 338:1128-1131.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.